Press Releases

LAS VEGAS, Nov. 13, 2019 /PRNewswire/ -- PROVE Holdings, LLC is redefining case management in the personal injury care business with its focus on strong partnerships, a patient centric approach, time-saving technology and customized financing options.The aftermath of an accident can be financially devastating for a family. PROVE works with law firms and

LAINATE, Italy, Nov. 13, 2019 /PRNewswire/ -- Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company focused on developing and commercializing prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced today that it has received approval from the German Authority BfArM and the coordinat

NESS ZIONA, Israel, Nov. 13, 2019 /PRNewswire/ --  ProteKt Therapeutics, a biotech company developing new PKR kinase inhibitor-based therapies for neurodegenerative diseases including Alzheimer's Disease, today announced the signing of a binding agreement for a $US 3.6 million equity financing round

NORTH CHICAGO, Ill., Nov. 13, 2019 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of November 11, 2019 its issued share capital, excluding treasury shares, is comprised of 1,478,830,254 shares of common stock with a par value of $0.0

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics, provided a business update and announced financial results for the third quarter ended

GOTHENBURG, Nov. 13, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced that the board of Isofol has decided that from today's date, November 13 2019, appoint the chairman of the board, Dr Jarl Ulf Jungnelius, M.D., as CEO of the company. Consequently, Ulf Jungnelius steps down from his po

STOCKHOLM, Nov. 13, 2019 /PRNewswire/ -- Bioservo has finished a successful long term trial with Ironhand® at Toyota Motor North America plants in Kentucky and West Virginia.Since April, Bioservo and Toyota has conducted a joint pilot project at the Kentucky

LINKÖPING, Sweden and ALMERE, the Netherlands, Nov. 13, 2019  /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra&

WATERTOWN, Mass., Nov. 13, 2019 /PRNewswire/ -- Arranta Bio ("Arranta") announced today the acquisition of Captozyme™, and with it the establishment of Arranta's Center of Excellence for process and analytical development and early clinical supply for microbiome clients with the transfer of the Captozyme team and facilities in

OSLO, Norway, Nov. 13, 2019 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that it will report its results for the third quarter 2019 on Tuesday, 19 November 2019. A presentation by Nordic Nanovector's senior management team will take place at 8:30am CET at:Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 OsloM